$0.278100
-0.05-14.30%
At close: -
$0.279000
0.00090.32%
After Hours: 7:57 PM EDT
Comments
Loading...
BioLine Rx (NASDAQ:BLRX) Stock, Earnings Estimates, EPS, And Revenue
BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 25
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$4.1M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$17M
Analyze the earnings history of BioLine Rx using advanced sorting and filters.
Data brought to you by Benzinga APIs
BioLine Rx (BLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-15 | $0 | $-0.14 | 100.0 % |
| Mar 2024 | 2024-05-28 | $-0.01 | $-0.29 | 96.5 % |
| Sep 2023 | 2023-11-20 | $-0.26 | $-0.21 | -23.8 % |
| Dec 2022 | 2023-03-22 | $-0.08 | $-0.14 | 42.9 % |
BioLine Rx (BLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-15 | $5.39M | $3.93M | 37.2 % |
FAQ
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx (BLRX) is scheduled to report earnings on November 25, 2024. The last reported earnings were for reported on August 15, 2024 for Q2.
What were the latest earnings per share (EPS) for BioLine Rx (NASDAQ:BLRX)?
The Actual EPS was $0.00, which beat the estimate of $-0.14.
What were BioLine Rx’s (NASDAQ:BLRX) revenues?
The Actual Revenue was $5.4M, which beat the estimate of $3.9M.
Browse earnings estimates, EPS, and revenue on all stocks.